Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical FactorsIris A S Stroot, Jan Brouwer, Joost Bart, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 8, 2022
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factorsMajke H D van Bommel, Miranda P Steenbeek, Joanna IntHout, et al.Journal of the National Cancer Institute|April 9, 2026
Menopause-related quality of life five years after salpingectomy with delayed oophorectomy versus Salpingo-OophorectomyTamar A Gootzen, Rosella Pmg Hermens, Marleen Mhj van Gelder, et al.Maturitas|February 23, 2026
Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA studyTamar A Gootzen, Marleen M H J van Gelder, Rosella P M G Hermens, et al.JAMA Oncology|June 3, 2021
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled TrialMiranda P Steenbeek, Marline G Harmsen, Nicoline Hoogerbrugge, et al.Nature Medicine|April 24, 2019
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneityOded Kopper, Chris J de Witte, Kadi Lõhmussaar, et al.Gynecologic Oncology|May 25, 2024
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriersIris A S Stroot, Joost Bart, Harry Hollema, et al.BJOG : an International Journal of Obstetrics and Gynaecology|January 17, 2025
Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference TrialMajke H D Van Bommel, Miranda P Steenbeek, Joanna Inthout, et al.BMJ Open|April 19, 2023
Cohort profile of PLUTO: a perioperative biobank focusing on prediction and early diagnosis of postoperative complicationsNikki de Mul, Diede Verlaan, Jelle P Ruurda, et al.Gynecologic and Obstetric Investigation|November 30, 2022
Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer ResearchHein S Zelisse, Mignon D J M van Gent, Sander de Ridder, et al.Pageof 8